News
RPHCF
15.20
NaN%
--
Rohto raises 2032 growth targets and boosts shareholder return plans
TipRanks · 10/05 05:22
Rohto Pharmaceutical Revises Long-Term Strategy, Recasts Growth Metrics as Rolling Forecasts
TipRanks · 10/05 05:22
Rohto Pharmaceutical to Outline Medium- to Long-Term Growth Strategy at Management Briefing
TipRanks · 10/02 01:22
Rohto Raises Long-Term Targets and Ups Shareholder Returns in Strategy Update
TipRanks · 10/02 01:22
Goldman Sachs Sticks to Their Hold Rating for Rohto Pharmaceutical Co (RPHCF)
TipRanks · 09/25 06:16
Rohto Pharmaceutical Completes Nearly ¥3 Billion Share Buyback
TipRanks · 09/15 06:53
Rohto Advances Share Buyback, Repurchases 595,400 Shares on TSE
TipRanks · 09/01 07:03
Rohto Pharmaceutical Lifts Full-Year Earnings Forecast on Strong Overseas Demand
TipRanks · 08/06 07:20
Rohto Pharmaceutical Delivers Q1 Sales Growth and Lifts Dividend Outlook
TipRanks · 08/06 07:20
Analysts Offer Insights on Consumer Goods Companies: Rohto Pharmaceutical Co (OtherRPHCF), Coca-Cola (KO) and Tyson Foods (TSN)
TipRanks · 07/14 12:41
Rohto Pharmaceutical Completes Delayed Acquisition of Thann Oryza
TipRanks · 05/29 07:02
Rohto Pharmaceutical Lowers Conversion Price on ¥25 Billion 2032 Convertible Bonds After Dividend
TipRanks · 05/21 07:02
Rohto Pharmaceutical Raises Dividend and Signals Further Payout Growth
TipRanks · 05/21 07:02
Rohto Board Rejects Shareholder Bid to Oust Veteran Director Kunio Yamada
TipRanks · 05/13 07:33
Rohto Pharmaceutical Lifts Dividend Forecast on Stronger Earnings Outlook
TipRanks · 05/13 07:33
Rohto Pharmaceutical Lifts Earnings, Strengthens Balance Sheet and Raises Dividend
TipRanks · 05/13 07:33
Rohto Faces Activist Shareholder Proposals Ahead of June Shareholders’ Meeting
TipRanks · 04/30 10:23
Rohto Pharmaceutical Launches ¥3 Billion Share Buyback to Boost Capital Efficiency
TipRanks · 03/26 07:00
Rohto Pharmaceutical Lifts Earnings Outlook and Hikes Dividend on Strong Overseas Performance
TipRanks · 02/12 08:11
Rohto Pharmaceutical Lifts Full-Year Outlook on Strong Nine-Month Earnings
TipRanks · 02/12 08:11
More
Webull provides a variety of real-time RPHCF stock news. You can receive the latest news about Rohto Pha through multiple platforms. This information may help you make smarter investment decisions.
About RPHCF
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).